PARTNERS

The collaborations
behind the science

Targa advances organ-rescue and cell-preservation science through clinical, academic, institutional, and strategic partnerships. We welcome collaborators who can help translate these technologies into clinical impact.

Clinical & research partnerships

Where the science is being validated

Targa’s first-in-human lung transplantation program is being prepared in Montréal with leading clinical and academic collaborators, combining transplant expertise, university-affiliated research infrastructure, and translational capabilities to advance TBM-005 toward human evaluation.

Accelerators, grants & ecosystem support

Supported by Canada’s leading life sciences ecosystem

From early R&D through to clinical readiness, Targa has been supported by a broad network of accelerators, granting bodies, and ecosystem partners.

Collaboration opportunities

Where we are looking to partner

With the science validated and the clinical program underway, Targa is seeking partners to support organ rescue and broader clinical translation.

Preservation & perfusion manufacturers
Strengthen DCD and marginal organ workflows

TBM-005 integrates with existing preservation and perfusion systems — additive, not competitive. The partnership with Targa extends clinical utility to the DCD organ segment without additional R&D.

Transplant programs & OPOs
Access more viable donor organs

Targa is engaging transplant centers and organ procurement organizations (OPOs) interested in expanding DCD organ utilization. Clinical study participation and early access opportunities are available.

Cell therapy manufacturers
Preserve cells. Simplify logistics.

Targa is developing advanced cell-storage and cryopreservation solutions designed to support cell viability and function across ambient, controlled-temperature, and cryopreservation workflows.

Scientific & research collaborators
Advance the science together

Targa welcomes conversations with academic institutions, research hospitals, and scientific organizations working in organ preservation, cell therapy, and regenerative medicine.

Targa partners with preservation and perfusion technology companies, including platforms, devices, and solutions. If our tech could enhance your organ-recovery offering, let’s connect.

Targa partners with preservation and perfusion technology companies, including platforms, devices, and solutions. If our tech could enhance your organ-recovery offering, let’s connect.